ArticleFrontiers in immunology2022

Heterodimeric IL-15 (hetIL-15) reduces circulating tumor cells and metastasis formation improving chemotherapy and surgery in 4T1 mouse model of TNBC.

Vasiliki Stravokefalou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.